THTX - Total Utang marang Modal Theratechnologies, Inc
Theratechnologies Inc. (THTX) focuses on implementing targeted oncology and HIV treatments while expanding its liver therapy portfolio. This chart of the total debt-to-equity ratio captures the metric at 0.00. Stable margins are maintained through the optimization of cross-border biologics shipments. Due to its macroeconomic independence and constant demand for innovation, the business serves as a reliable defensive asset.
%20-%20Rasio%20Kabeh%20Utang%20marang%20Dana%20Pribadi&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261030&filename=GURU_Markets_-_THTX_-_Theratechnologies-Inc._-_All-Debt-to-Shareholders-Equity-Ratio "THTX (Theratechnologies Inc.) riwayat Total Utang marang Modal saka 04.07.2022 nganti 11.10.2025 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan Theratechnologies Inc.
- rega lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- indikator kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Theratechnologies Inc.|THTX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Theratechnologies Inc.|THTX - Gunggung utang perusahaan|Utang marang nilai buku Theratechnologies|THTX - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Theratechnologies|Likuiditas cepet theratech.com
- informasi bathi lan kelipatan valuasi:
Analisis dhasar perusahaan:Theratechnologies
Developing innovative peptide drugs requires colossal investments in targeted protein engineering. This ratio compares the total liabilities of Theratechnologies Inc. (THTX) to its net assets, reflecting the funding structure of its R&D. The metric measures the level of financial leverage and the biopharmaceutical business's dependence on external borrowings. High values signal a risk of liquidity shortages amid rising Fed rates. By analyzing the business's debt-to-equity ratio, an investor assesses the company's resilience to market shocks.
Analisis pesaing Theratechnologies Inc.
Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PHVS (Pharvaris Corp)|Koefisien Total Utang marang Modal AbCellera (ABCL)|TRML - Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|Pharming Group (PHAR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|Rasio Total Utang marang Ekuitas UPB|Total Utang marang Modal Zenas Corp|Utang marang Ekuitas Immunome, Inc. (IMNM)|gossamerbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Utang marang Modal|PVLA: Rasio Total Utang marang Ekuitas|Savara Pharma - Utang Agregat marang Modal|RIGL: Total Utang marang Modal|anaptysbio.com - Rasio Kabeh Utang marang Dana Pribadi|ATXS (Astria Therapeutics, Inc.) - Total Utang marang Modal|Utang marang Modal enGene Holdings Inc ENGN|Utang marang Ekuitas RAPT Therapeutics, Inc. (RAPT)|JBIO (aerovatetx.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ACRS (Aclaris Therapeutics)|Total Utang marang Modal kyvernatx.com KYTX|TLSA: Rasio Total Utang marang Ekuitas|Cabaletta Bio Inc. - Utang Agregat marang Modal|VTYX: Total Utang marang Modal|Utang marang Modal Avalo Therapeutics Inc (AVTX)|ELDN (Eledon Pharmaceuticals) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas agenusbio.com (AGEN)|Total Utang marang Modal CLYM|ZURA (Zura Bio Ltd) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas aTyr ATYR|ADAG: Rasio Utang marang Ekuitas|IMA - Utang marang Ekuitas|Utang marang Modal Shattuck Labs, Inc.|equilliumbio.com (EQ) - Utang marang Ekuitas|CNTB (Connect Biopharma Holdings Limited) - Utang marang Ekuitas|Utang marang Ekuitas Immunic Therapeutics|Utang marang Modal Atara Biotherapeutics Inc ATRA|Total Utang marang Modal IFRX|x4pharma.com (XFOR) - Rasio Utang marang Modal|Total Utang marang Modal ACET (Adicet Bio, Inc.)|Koefisien Total Utang marang Modal Celularity Inc (CELU)|INmune Bio Corp - Total Utang marang Modal|Utang marang Modal Barinthus Biotherapeutics Corp|Kezar Life Sciences (KZR) - Utang marang Ekuitas|SABS - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas AKTX|ENLV: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal QTTB|Koefisien Total Utang marang Modal GeoVax Corp|Utang marang Ekuitas Edesa Biotech, Inc. EDSA|IBIO: Rasio Utang marang Ekuitas|Carisma Tx - Total Utang marang Modal|XTL Biopharmaceuticals Ltd (XTLB) - Rasio Total Utang marang Ekuitas|BOLT (boltbio.com) - Rasio Total Utang marang Ekuitas|HCWB - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas APVO|AIM (AIM ImmunoTech, Inc.) - Utang Agregat marang Modal|Total Utang marang Modal ADTX|GRI (GRI Bio Inc) - Rasio Kabeh Utang marang Dana Pribadi|XORTX - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal HIND (Vyome Therapeutics)|REVB: Rasio Total Utang marang Ekuitas|INDP (indaptusrx.com) - Rasio Utang marang Ekuitas|Scinai Immunotherapeutics Ltd. (SCNI) - Utang marang Ekuitas|Utang Agregat marang Ekuitas CALI (CalciMedica)|AFMD (Affimed NV) - Total Utang marang Modal|ALLK: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal HOOK|Total Utang marang Modal igmbio.com (IGMS)|Utang marang Ekuitas iTeos Therapeutics, Inc. ITOS|Rasio Kabeh Utang marang Dana Pribadi OCEA|TCBP - Utang marang Ekuitas|Third Harmonic Bio Inc (THRD) - Rasio Total Utang marang Ekuitas